Topics

Companies Related to "Developing Quality Cancer Survivorship Care Framework Implications Clinical∨derfield=score∨derval=DESC" [Most Relevant Company Matches] [Advanced Search Results] RSS

10:48 EDT 21st July 2019 | BioPortfolio

Here are the most relevant search results for "Developing Quality Cancer Survivorship Care Framework Implications Clinical∨derfield=score∨derval=DESC" found in our extensive corporate database of over 50,000 company records.

Showing "Developing Quality Cancer Survivorship Care Framework Implications Clinical" Companies 1–25 of 17,000+

Friday 19th July 2019

GenesisCare

GenesisCare delivers treatment to people with cancer and heart disease, the two largest disease burdens globally. We’re committed to leading the change in how care is designed and given and are currently leading or participating in more than 100 clinical trials.


Algiax Pharmaceuticals

Algiax Pharmaceuticals is a clinical-stage biotechnology company established in 2011. It is dedicated to the discovery and development of innovative products to treat diseases with a high unmet medical need. Algiax’ lead candidate AP-325 is a small-molecule GABAA receptor modulator in clinical development as a therapy for neuropathic pain.

Thursday 18th July 2019

Nexien BioPharma, Inc.

Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid pharmaceuticals in accordance with U.S. Food and Drug Administration ("FDA") pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. For more information, visit Nexien BioPharma’s ...


Ardian

Ardian, Inc., headquartered in Palo Alto, California, is a private medical device company developing a novel catheter-based treatment for diseases related to sympathetic hyperactivity, including hypertension, chronic kidney disease, insulin resistance and heart failure. These interdependent disease states represent a significant, escalating global health issue. Ardian is the eighth company created...

Wednesday 17th July 2019

AUM Biosciences

AUM Biosciences (AUM) is an oncology-focused Asian biotechnology company committed to developing affordable cancer therapies. Dedicated to unlocking the value in innovation, AUM harnesses the power of precision medicine and digital health to support patients, physicians and partners. AUM focuses on early-stage development of innovative treatment of cancers prevalent in Asia with the potential to ...

​Revance Therapeutics, Inc.

Revance Therapeutics is a biotechnology company focused on developing transformative neuromodulators to address a broad spectrum of aesthetic and therapeutic conditions. Revance’s lead product candidate, DaxibotulinumtoxinA for Injection (DAXI), utilizes a unique proprietary peptide excipient technology combined with highly purified botulinum toxin type A to produce a novel, long-acting neur...

Frequency Therapeutics, Inc.

Frequency Therapeutics is a biotech company focused on developing small molecule drugs that stimulate cells in the body to reverse biological deficits and restore healthy tissue. Through the transitory activation of these cells, Frequency aims to develop therapies that can enable disease modification without the complexity of genetic engineering. Our development candidates use a proprietary combi...

Orum Therapeutics, Inc.

Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics. In contrast to other approaches, Orum...

Tuesday 16th July 2019

Change Healthcare Inc.

Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system. We are a key catalyst of a value-based healthcare system, accelerating the journey toward improved lives and healthier communities.

Constellation Behavioral Health

Founded in 2010, Constellation is dedicated to creating and operating innovative treatment programs for adults with addiction, mental health and co-occurring disorders. Constellation was founded on the belief that excellent treatment outcomes require an intense focus on diagnosing and treating co-occurring disorders, and that a treatment program’s success ...

NaphCare, Inc.

NaphCare, Inc., partners with city, county, state and federal correctional facilities nationwide to provide proactive, patient-focused healthcare to more than 125,000 patients. The company’s innovative approach to correctional healthcare includes designing and implementing evidence-based clinical programs to address the specific challenges of the corrections environment. NaphCare provides co...

Altarum and Catalyst for Payment Reform

Catalyst for Payment Reform is an independent, nonprofit organization working to catalyze employers, public purchasers and others to implement strategies that produce higher-value health care and improve the functioning of the health care marketplace.

Ra Pharmaceuticals and Camurus AB

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Monday 15th July 2019

BioCurate Pty Ltd

BioCurate Pty Ltd was formed jointly in June 2016 by The University of Melbourne and Monash University, with support from the Victorian State Government to accelerate early phases of new drug development. BioCurate is seeking to address the key challenges in early stage drug development and to increase the number, quality and rate of translation of new drug discoveries into medically sound projec...

Imugene Ltd

Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the body’s immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and oth...

Friday 12th July 2019

YogaWorks

YogaWorks, Inc. is one of the largest providers of high-quality yoga instruction in the U.S., with 68 studios in nine markets including Los Angeles, Orange County, Northern California, New York City, Boston, Baltimore, the Washington, D.C. area, Houston and Atlanta. YogaWorks strives to make yoga accessible to everybody and offers a wide range of class styles for people of all ages and abilities....

Fontem US Inc.

Designed for smokers, by smokers, blu has been a trusted leader of adult consumer satisfaction since launching in 2009. blu's top priority and mission continues to be exceeding the needs of adult smokers with high quality vapor products and e-liquid flavors. blu is available online and in stores across the four largest vapor markets worldwide, including the USA, UK, France and Italy. The brand is...

Siemens Healthineers & University of Missouri System & University of Missouri Health Care

Thursday 11th July 2019

Rasmussen College

To help meet employer demands, Rasmussen College’s hands-on PTA program is designed to help students earn their degree in an immersive setting, develop their confidence and arm them with the skills employers seek. Students learn to improve a patient’s mobility and decrease pain, as well as gain the ability to comfortably and confidently interact with professionals and patients in a vari...

Medical Economics®

Medical Economics® is a digital and print multimedia platform that provides physicians with expert advice, shared experiences, tools and resources to succeed in today’s practice environment. As the highest-ranked practice management publication in the market, Medical Economics® covers topics including primary care, the business of medicine, heal...

Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...

Wednesday 10th July 2019

Shore Capital Partners and SouthStar Urgent Care

Osivax

Osivax’s mission is to revolutionize influenza prevention with a universal flu vaccine for both current and future Influenza A and B infections by leveraging its unique oligoDOM® technology platform. The most advanced candidate, a broad-spectrum A-strain flu vaccine is in Phase 1 clinical development. Osivax is focused on providing proof-of-concept in Influenza A firstly to save lives and...

CMIC HOLDINGS Co., Ltd.

CMIC Group started business in 1992 as the first CRO in Japan, today the company provides comprehensive support services for the development, manufacturing, sales and marketing of pharmaceutical products. The company also operates to respond to diversifying needs by managing the Healthcare Business sector and developing and selling diagnostic pharmaceuticals and orphan drugs. CMIC Group has devel...

Tuesday 9th July 2019

The MEDICREA Group

Through the lens of predictive medicine, Medicrea leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room.


More From BioPortfolio on "Developing Quality Cancer Survivorship Care Framework Implications Clinical∨derfield=score∨derval=DESC"

Quick Search

Corporate Database Quicklinks